| Dr Steven Kyriakos Constantino Jr, MD | |
|
75 Francis St, Boston, MA 02115-6110 | |
| (617) 732-8210 | |
| Not Available |
| Full Name | Dr Steven Kyriakos Constantino Jr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 75 Francis St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205199627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 251587 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Maine Medical Center | 2567379563 | 347 |
| Spectrum Healthcare Partners Pa | 7618871245 | 265 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040127000198 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Bridgton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154370153 PECOS PAC ID: 8123919099 Enrollment ID: O20040322000534 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Anesthesia Associates Of Lewiston-auburn, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225074362 PECOS PAC ID: 7911898796 Enrollment ID: O20040322001303 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Rumford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205991122 PECOS PAC ID: 3870583511 Enrollment ID: O20040514000890 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040915000845 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Kyriakos Constantino Jr, MD 52 Little Pond Rd, Merrimac, MA 01860-2258 Ph: () - | Dr Steven Kyriakos Constantino Jr, MD 75 Francis St, Boston, MA 02115-6110 Ph: (617) 732-8210 |
News Archive
Patients with Chronic Obstructive Pulmonary Disease (COPD) are increasingly being prescribed inhaled corticosteroids to control exacerbations of the disease, but a new study finds that the anti-inflammatory drugs increase the chances that these patients will be hospitalized for pneumonia.
An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.
Clinical Data, Inc. today announced the closing of its previously announced public offering of 2,237,412 newly issued shares of common stock, including 291,836 shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters, at a price to the public of $14.30 per share.
A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.
› Verified 3 days ago
Stephen G. Flynn, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Dr. Dusan Hanidziar, M.D., PH.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Gray-bigelow 444, Boston, MA 02114 Phone: 617-726-3030 | |
Dr. Michael Christopher Lubrano, M.D., M.P.H. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-8210 | |
Vahid Kiarad, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Kendrick M Shaw, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-3030 | |
John William Carl Carter Mallett, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. David Joswick, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 800 Washington St, Boston, MA 02111 Phone: 617-636-5000 |